The influence of comorbidities on COVID-19 outcomes has been recognized since the
earliest days of the pandemic. But establishing causality and determining underlying …

The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …

Background Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …

Eighteen months into the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)(coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that …

Objectives: Pre-existing or new diabetes confers an adverse prognosis in people with Covid-
19. We reviewed the clinical literature on clinical outcomes in metformin-treated subjects …

Background Diabetes mellitus (DM) is a critical risk factor for severe SARS-CoV-2 infection,
and SARS-CoV-2 infection contributes to worsening glycemic control. The COVID-19 …

The COVID-19 pandemic, which was caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a worldwide health crisis due to its …

The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …

The aim To study the association of demographic, clinical, and laboratory factors and the
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …